# Pipeline Activity Log

> **Review:** Adjuvant progestagens for endometrial cancer  
> **Date:** 2026-05-21 23:34  
> **Duration:** 17m 44s  
> **Total tokens:** 183,862 (input: 107,097 / output: 76,765)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001040.pub2/full  
> **Dataset split:** dev  
> **Studies:** 10  
> **Model Profile:** multimodel_openrouter  
> **Orchestrator Model:** openai | openai/gpt-5  
> **Orchestrator API Base:** https://openrouter.ai/api/v1  
> **Orchestrator Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Librarian Model:** openai | openai/gpt-5  
> **Librarian API Base:** https://openrouter.ai/api/v1  
> **Librarian Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Gatekeeper Model:** openai | deepseek/deepseek-v4-pro  
> **Gatekeeper API Base:** https://openrouter.ai/api/v1  
> **Gatekeeper Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["deepseek"], "require_parameters": true}, "reasoning": {"effort": "xhigh", "enabled": true}}}  
> **Miner Model:** openai | openai/gpt-5  
> **Miner API Base:** https://openrouter.ai/api/v1  
> **Miner Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Critic Model:** openai | openai/gpt-5  
> **Critic API Base:** https://openrouter.ai/api/v1  
> **Critic Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 8 | 17m 44s | 56,212 / 21,866 |
| Librarian | 3 | 2m 41s | 10,989 / 11,807 |
| Gatekeeper | 1 | 2m 03s | 4,898 / 4,151 |
| Miner | 2 | 2m 52s | 9,288 / 13,994 |
| Critic | 3 | 5m 40s | 25,710 / 24,947 |
| **Total** | **17** | **17m 44s** | **107,097 / 76,765** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*23:35:12 — 45s — 5,186 tokens*

The orchestrator reviewed the review question and protocol on adjuvant progestagen therapy after surgery for endometrial cancer and mapped out a stepwise workflow. It planned for specialized agents to retrieve the literature and create a standardized candidate list, screen studies against the RCT postoperative-therapy criteria, extract PICO details (population, progestagen type/dose, comparators), outcomes (survival, recurrence, adverse events), follow-up, and risk-of-bias, and then synthesize findings on effectiveness and safety. The outcome was a clear plan to produce a concise report and a structured evidence file while tracking the number of retrieved and included studies, setting up the next execution steps.

---

### 2. Orchestrator → Librarian

*23:38:23 — 3m 11s — 31,321 tokens*

The orchestrator initiated the search phase for the review on adjuvant progestagens after surgery for endometrial cancer, supplying the protocol and directing a librarian agent to perform a comprehensive search for relevant RCTs. It then retrieved a structured list of candidate studies and tallied the yield. Outcome: 10 candidate studies were identified, and this count was recorded for later reporting.

> **Librarian — Step 1:** The librarian agent first confirmed the review scope before searching by retrieving the protocol for a review on adjuvant progestagens for endometrial cancer. It obtained the background, objective, and eligibility criteria, which specify randomized controlled trials of postoperative progestagen therapy. This information will guide the construction of the literature search strategy; no database searching was performed in this step.
> **Librarian — Step 2:** The librarian agent built a comprehensive PICO-aligned search targeting randomized trials of adjuvant progestagens after surgery for endometrial cancer and ran it in the literature database. The search returned 10 candidate records, and the raw results were captured for downstream structuring. Notable hits included a multicenter RCT evaluating adjuvant medroxyprogesterone and at least one review article.
> **Librarian — Step 3 (result):** The librarian agent aimed to retrieve and organize candidate studies for randomized trials of adjuvant progestagen therapy after surgery for endometrial cancer. It parsed the database’s raw output into a structured list of 10 records with titles and abstracts, and documented the PICO-based search strategy, including the exact query used. The output lacks additional bibliographic details and may include some non-RCTs to be addressed during screening.

---

### 3. Orchestrator → Gatekeeper

*23:40:52 — 2m 29s — 18,095 tokens*

The orchestrator moved to the screening phase, directing the gatekeeper to apply the protocol’s selection criteria to each candidate study and provide include/exclude decisions with reasons. It then attempted to collect the included studies and count how many were retained. This failed at the counting step because the extracted output was not in the expected format, resulting in an error and no inclusion count being produced.

> **Gatekeeper — Step 1 (result):** The gatekeeper screened 10 studies against the criterion of randomized controlled trials of adjuvant progestagen therapy in women after surgery for endometrial cancer. It included four RCTs (studies 1, 5, 7, and 10) and excluded six items that were reviews, methodological papers, or not clearly randomized. Confidence was high for all inclusion/exclusion decisions except the non-randomized controlled study, which had medium confidence.

> ⚠️ **Error:** Code execution failed at line 'included_count = len(included_data.get("studies", []))' due to: InterpreterError: Object [{'study_index': 1, 'title': 'Treatment of FIGO (1971) stage 1 endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic gr

---

### 4. Orchestrator (python_interpreter)

*23:41:46 — 54s — 11,754 tokens*

The orchestrator corrected a previous counting error by directly tallying the items in the previously returned list of included studies. It recalculated the total without calling other agents and confirmed there are 4 included studies. This resolves the discrepancy and prepares for the next step of evidence extraction.

---

### 5. Planning (Orchestrator)

*23:42:31 — 45s — 7,858 tokens*

The orchestrator reviewed the protocol and current progress, confirming that 10 candidate studies were found and 4 randomized trials met the inclusion criteria after screening. It planned the remaining steps: extract outcome data on effectiveness and safety from the four trials, synthesize the evidence, format the report, and save the structured outputs before returning the final report.

---

### 6. Orchestrator → Miner

*23:45:48 — 3m 16s — 35,044 tokens*

The orchestrator initiated the extraction phase by directing an evidence-mining agent to pull structured PICO data from the included randomized trials in line with the review objective. It requested detailed capture of population characteristics, progestagen regimens (agent, dose, schedule, duration), comparators, survival/recurrence and adverse event outcomes, effect measures with 95% CIs, follow-up, and key trial methods. The extraction step completed, and the structured evidence was recorded for subsequent synthesis.

> **Miner — Step 1:** The agent set out to extract structured PICO elements and key outcomes from all included studies on adjuvant progestagens for endometrial cancer. It processed four study abstracts in batch, capturing population, interventions (with dose/schedule when reported), comparators, outcomes with any effect measures or p-values, follow-up, and study design, and noted when numerical effect sizes were not available. The outcome was a set of structured summaries per study; for example, one multicenter randomized trial reported no significant difference in relapse-free survival with adjuvant medroxyprogesterone acetate compared with control.
> **Miner — Step 2 (result):** The miner aimed to produce a structured, study-by-study evidence summary from the included randomized trials’ abstracts. It extracted the population, interventions (with dose/schedule when stated), comparators, outcomes (overall and relapse-free survival, recurrence), follow-up, study design, and key findings, recording p-values when available and leaving effect sizes and confidence intervals blank if not reported. The resulting output includes, for example, a multicenter Stage I endometrial carcinoma trial showing no improvement in relapse-free or overall survival with adjuvant medroxyprogesterone, and no adverse events were reported.

---

### 7. Orchestrator → Critic

*23:51:54 — 6m 06s — 62,434 tokens*

The orchestrator advanced to the synthesis stage, directing a quality-assessment/synthesis agent to evaluate risk of bias for each included randomized trial and produce a narrative synthesis aligned with the review objective. It provided the extracted evidence and requested summaries of effectiveness and safety outcomes, discussion of heterogeneity (e.g., by risk strata), and practice/research implications with study citations. The synthesis completed successfully, and the resulting assessment and narrative were stored for inclusion in the final report.

> **Critic — Step 1:** The critic aimed to appraise study quality and synthesize findings by first extracting the miner’s structured evidence from the provided text. It successfully parsed the dataset, identifying four studies and listing their citations. This prepared clean, structured input for the upcoming quality assessment and narrative synthesis steps.
> **Critic — Step 2:** The agent initiated a formal quality review of the mined evidence to prepare for synthesis. It applied an evidence-quality tool to the parsed study data and logged the output, which summarized a randomized multicentre trial of adjuvant medroxyprogesterone acetate for stage I endometrial cancer and listed key outcomes without effect estimates. This produced a traceable record of the study details for use in the subsequent synthesis and appraisal.
> **Critic — Step 3 (result):** The agent aimed to synthesize the extracted evidence on adjuvant progestagen therapy for endometrial cancer and assess the quality of each included study. It reviewed the randomized trials, produced study-level risk-of-bias appraisals, and wrote a narrative synthesis covering survival, recurrence, safety, heterogeneity, and implications for practice and research. The synthesis found no consistent benefit for overall or disease-free survival and noted a potential increase in non-cancer mortality, leading to the conclusion that routine use is not supported and should be limited to clinical trials.

---

### 8. Final Output (Orchestrator)

*23:52:12 — 18s — 12,170 tokens*

The orchestrator finalized the review by compiling the screening, evidence extraction, and synthesis outputs into a single report. It produced the report for adjuvant progestagens in endometrial cancer, noting 10 candidate studies (4 included, 6 excluded with reasons) and summarizing key details from the included trials. It also saved the structured screening, evidence, and synthesis data for future reference and returned the completed report.

---
